News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
770,400 Results
Type
Article (54877)
Company Profile (402)
Press Release (715103)
Multimedia
Podcasts (168)
Webinars (25)
Section
Business (217942)
Career Advice (2904)
Deals (38134)
Drug Delivery (138)
Drug Development (87149)
Employer Resources (182)
FDA (17643)
Job Trends (16035)
News (371459)
Policy (35791)
Tag
Academia (2696)
Academic (1)
Accelerated approval (18)
Adcomms (35)
Allergies (122)
Alliances (54677)
ALS (145)
Alzheimer's disease (1670)
Antibody-drug conjugate (ADC) (259)
Approvals (17678)
Artificial intelligence (475)
Autoimmune disease (96)
Automation (29)
Bankruptcy (382)
Best Places to Work (11940)
BIOSECURE Act (23)
Biosimilars (167)
Biotechnology (247)
Bladder cancer (138)
Brain cancer (51)
Breast cancer (506)
Cancer (4026)
Cardiovascular disease (346)
Career advice (2460)
Career pathing (38)
CAR-T (250)
CDC (57)
Cell therapy (683)
Cervical cancer (32)
Clinical research (72799)
Collaboration (1421)
Company closure (4)
Compensation (948)
Complete response letters (61)
COVID-19 (2884)
CRISPR (81)
C-suite (606)
Cystic fibrosis (137)
Data (4720)
Decentralized trials (2)
Denatured (57)
Depression (110)
Diabetes (441)
Diagnostics (6720)
Digital health (35)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (214)
Drug pricing (194)
Drug shortages (35)
Duchenne muscular dystrophy (205)
Earnings (91051)
Editorial (55)
Employer branding (22)
Employer resources (160)
Events (123558)
Executive appointments (987)
FDA (20188)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1258)
Gene editing (173)
Generative AI (42)
Gene therapy (543)
GLP-1 (1021)
Government (4665)
Grass and pollen (8)
Guidances (370)
Healthcare (18988)
HIV (47)
Huntington's disease (41)
IgA nephropathy (64)
Immunology and inflammation (253)
Immuno-oncology (22)
Indications (57)
Infectious disease (3132)
Inflammatory bowel disease (190)
Inflation Reduction Act (16)
Influenza (100)
Intellectual property (197)
Interviews (529)
IPO (17313)
IRA (59)
Job creations (4477)
Job search strategy (2049)
Kidney cancer (16)
Labor market (77)
Layoffs (629)
Leadership (37)
Legal (8903)
Liver cancer (90)
Longevity (12)
Lung cancer (579)
Lymphoma (268)
Machine learning (31)
Management (63)
Manufacturing (658)
MASH (145)
Medical device (14094)
Medtech (14118)
Mergers & acquisitions (21732)
Metabolic disorders (1156)
Multiple sclerosis (140)
NASH (23)
Neurodegenerative disease (228)
Neuropsychiatric disorders (62)
Neuroscience (2718)
NextGen: Class of 2025 (6911)
Non-profit (4326)
Now hiring (59)
Obesity (567)
Opinion (309)
Ovarian cancer (140)
Pain (170)
Pancreatic cancer (173)
Parkinson's disease (242)
Partnered (30)
Patents (427)
Patient recruitment (333)
Peanut (54)
People (62956)
Pharmaceutical (112)
Pharmacy benefit managers (29)
Phase I (22547)
Phase II (31820)
Phase III (24105)
Pipeline (2807)
Policy (301)
Postmarket research (2913)
Preclinical (9569)
Press Release (70)
Prostate cancer (202)
Psychedelics (52)
Radiopharmaceuticals (277)
Rare diseases (688)
Real estate (6798)
Recruiting (72)
Regulatory (25917)
Reports (51)
Research institute (2492)
Resumes & cover letters (456)
Rett syndrome (16)
RNA editing (15)
RSV (75)
Schizophrenia (138)
Series A (213)
Series B (160)
Service/supplier (20)
Sickle cell disease (80)
Special edition (26)
Spinal muscular atrophy (164)
Sponsored (41)
Startups (4042)
State (2)
Stomach cancer (17)
Supply chain (102)
Tariffs (96)
The Weekly (109)
Vaccines (1045)
Venture capital (68)
Weight loss (402)
Women's health (59)
Worklife (21)
Date
Today (57)
Last 7 days (699)
Last 30 days (2691)
Last 365 days (32220)
2025 (26857)
2024 (36900)
2023 (41668)
2022 (52763)
2021 (57291)
2020 (55713)
2019 (48195)
2018 (36489)
2017 (34978)
2016 (35412)
2015 (41029)
2014 (35597)
2013 (30186)
2012 (32168)
2011 (32479)
2010 (31105)
Location
Africa (945)
Alabama (80)
Alaska (7)
Arizona (294)
Arkansas (13)
Asia (46115)
Australia (7483)
California (9565)
Canada (2857)
China (931)
Colorado (398)
Connecticut (425)
Delaware (273)
Europe (104254)
Florida (1418)
Georgia (316)
Hawaii (3)
Idaho (67)
Illinois (782)
India (52)
Indiana (473)
Iowa (18)
Japan (334)
Kansas (121)
Kentucky (37)
Louisiana (18)
Maine (76)
Maryland (1281)
Massachusetts (7104)
Michigan (304)
Minnesota (561)
Mississippi (4)
Missouri (116)
Montana (32)
Nebraska (26)
Nevada (106)
New Hampshire (75)
New Jersey (2658)
New Mexico (30)
New York (2586)
North Carolina (1367)
North Dakota (10)
Northern California (4415)
Ohio (290)
Oklahoma (19)
Oregon (42)
Pennsylvania (1954)
Puerto Rico (20)
Rhode Island (44)
South America (1361)
South Carolina (51)
South Dakota (1)
Southern California (3685)
Tennessee (149)
Texas (1480)
United States (34985)
Utah (276)
Virginia (241)
Washington D.C. (82)
Washington State (798)
West Virginia (4)
Wisconsin (95)
Wyoming (2)
770,400 Results for "biopharma solutions baxter s pharma biotech partnering business".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Halozyme’s $900M Elektrofi Buyout Brings Two Big Pharma Partners Together
Both Halozyme and Elektrofi have partnered with several Big Pharma companies to provide drug delivery technologies.
October 2, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Ryght AI Partners with Global CRO Biorasi to Deliver AI-Powered Feasibility Solutions to Biotech and Biopharma Sponsors
August 18, 2025
·
4 min read
Editorial
GSK CEO Emma Walmsley’s Departure Reseals Pharma’s Glass Ceiling
After Emma Walmsley steps down as GSK CEO in January, Vertex Pharma’s Reshma Kewalramani will be the sole female CEO at a top-20 pharma company. Still, there are many prominent women in pharma that could someday break through again.
September 29, 2025
·
1 min read
·
Annalee Armstrong
Mergers & acquisitions
5 SMID-Cap Pharmas Poised for M&A Action
Mergers and acquisitions are not just for Big Pharma. A new report from Leerink Partners takes a stab at identifying the small- to mid-cap pharmas best prepared to bolster their pipelines with a buyout.
October 29, 2025
·
7 min read
·
Annalee Armstrong
Special edition
Deep Dive: Chinese Biotech Innovation Can’t Be Stopped
In this deep dive,
BioSpace
investigates China’s rise as a biotech powerhouse.
October 27, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
Umoja Biopharma Named One of 2025’s Most Promising Biotech Companies by Endpoints News and Fierce Biotech
September 24, 2025
·
2 min read
Press Releases
Uniphar announces U.S. expansion, integrating leading companies and appointing new senior leadership
- New integration aligns U.S. operations, unifying RRD BioPharma Development, Uniphar Clinical, Diligent Health Solutions and BESTMSLs under the Uniphar brand. - Mike Ebhardt is appointed President of Uniphar Pharma Services U.S., alongside Cindy Thompson as Vice President of Operations and Transformation.
November 3, 2025
·
1 min read
C-suite
The 5 Most Powerful Women in Biopharma
As the industry loses one of its key female leaders in GSK CEO Emma Walmsley,
BioSpace
profiles the women leading the industry’s smaller biopharmas.
October 8, 2025
·
6 min read
·
Annalee Armstrong
Job Trends
Almost 1/3 Eyeing Job Options Outside US,
BioSpace
Finds
Nearly one-third of biotech and pharma professionals are thinking about leaving the U.S. to find biopharma jobs, according to a
BioSpace
LinkedIn poll. Career coaches discuss why people are considering relocating and what they should do before heading for the exit.
October 30, 2025
·
4 min read
·
Angela Gabriel
Opinion
A Flu Season in Flux Presents Risks, Opportunities for Biopharma
The coming flu season is the clearest indication yet that biopharma’s long-standing assumptions about predictability, prevention and portfolio structure are no longer guaranteed.
October 28, 2025
·
7 min read
·
Tom Sebok
1 of 77,040
Next
